T cells that recognize HER2 teceptor may prevent HER2+ breast cancer recurrence

[News]

Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer -induced weakness in the patient's immune system - a weakness that in principle could be...

More... (http://www.medicalnewstoday.com/releases/304606.php)